Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVALBUTEROL for Chronic obstructive pulmonary disease: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 145 adverse event reports in the FDA FAERS database where LEVALBUTEROL was used for Chronic obstructive pulmonary disease.

Most Reported Side Effects for LEVALBUTEROL

Side Effect Reports % Deaths Hosp.
Device delivery system issue 459 31.8% 0 7
Drug dose omission by device 395 27.3% 0 2
No adverse event 393 27.2% 0 0
Dyspnoea 224 15.5% 1 31
Drug ineffective 181 12.5% 2 15
Asthma 105 7.3% 0 13
Off label use 97 6.7% 19 17
Cough 70 4.8% 1 10
Device issue 68 4.7% 0 5
Incorrect dose administered by device 59 4.1% 0 1
Product use in unapproved indication 56 3.9% 2 9
Tremor 50 3.5% 0 6
Pneumonia 45 3.1% 29 12
Chronic obstructive pulmonary disease 42 2.9% 0 4
Palpitations 41 2.8% 0 5

Other Indications for LEVALBUTEROL

Product used for unknown indication (482) Asthma (285) Dyspnoea (63) Wheezing (22) Cerebral palsy (21) Cystic fibrosis (13) Bronchitis (11) Emphysema (11) Cough (10) Graft versus host disease in eye (9)

Other Drugs Used for Chronic obstructive pulmonary disease

TIOTROPIUM (20,175) FLUTICASONE\SALMETEROL (8,896) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (8,730) ALBUTEROL (8,572) BUDESONIDE\FORMOTEROL (6,539) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (4,580) UMECLIDINIUM\VILANTEROL TRIFENATATE (4,512) DUPILUMAB (3,526) ALBUTEROL\IPRATROPIUM (3,289) ACLIDINIUM (2,321)

Related Pages

LEVALBUTEROL Full Profile All Chronic obstructive pulmonary disease Drugs LEVALBUTEROL Demographics LEVALBUTEROL Timeline